Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dana-Farber Cancer Institute
With
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
* Within 4 weeks of the patient's scheduled surgery they will undergo a C11 acetate PET scan. This scan will be performed at the Massachusetts General Hospital's Nuclear Medicine Department and involves an intravenous injection of acetate with a radioactive tracer followed by a PET scan. The scan will determine how well the tumor is taking up the acetate.
* Patients will also undergo a CT scan of the pelvis at the same time as the PET scan.
* After surgery, the removed tumor will have additional testing that will look at different factors that may tell us how aggressive the tumor is and how much FAS is within the tumor. FAS seems to be produced in higher amounts by prostate cancer cells than normal cells. We will then try to determine if the results of the C11 acetate PET scan can tell us how much FAS is produced by prostate cancer cells.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically documented prostate cancer
Planned radical prostatectomy
\> 50% cores positive for prostate cancer from prostate biopsy or a palpable prostate nodule
Older than 18 years of age
You may not be if
Inability to lay on a scanner for 60 minutes
Clareo Health | Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer
